Susan M Domchek MD
Breast Cancer, Cancer Genetics/Cancer Risk Assessment, Hematologic Oncology
Basser Professor of Medicine, University Pennsylvania
Join to View Full Profile
3400 Spruce St# 15Philadelphia, PA 19104
Phone+1 215-662-3914
Dr. Domchek is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1998 - 2001
Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 1995 - 1998
Harvard Medical SchoolClass of 1995
Certifications & Licensure
NJ State Medical License 2022 - 2027
NY State Medical License 2024 - 2026
PA State Medical License 2001 - 2026
NC State Medical License 2020 - 2022
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014-2017
Clinical Trials
- Vaccine Plus Montanide ISA-51 and Sargramostim in Treating Patients With Stage IV Breast Cancer Start of enrollment: 2004 Feb 01
- Tamoxifen-MRI Study Start of enrollment: 2000 Sep 01
- Single Nucleotide Polymorphism (SNP) Panels and Risk Assessment in Women Undergoing Mammography Start of enrollment: 2010 Feb 01
Publications & Presentations
PubMed
- Sexual Function, Activity and Distress 24 Months After Surgical Menopause: What Happens After Menopause (WHAM)-A Prospective Controlled Study.Martha Hickey, Trevor Tejada-Berges, Susan M Domchek, Efrosinia O Krejany, Alison Brand
BJOG. 2026-05-01 - A randomized study of digital versus genetic counselor return of actionable genetic research results to biobank participants (RESPECT3 study).Anuja Rajendra Godbole, Elisabeth Wood, Brian Egleston, Lily Hoffman-Andrews, Sarah Brown
BMC Medical Ethics. 2026-03-31 - TBCRC 048 (Olaparib Expanded) Expansion Cohorts: Phase II Study of Olaparib Monotherapy for Patients With Metastatic Breast Cancer With Germline Mutations inor Somatic...Nadine M Tung, Mark E Robson, Tianyu Li, Rita Nanda, Payal D Shah
Journal of Clinical Oncology. 2026-03-10
Journal Articles
- Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization StudySusan M Domchek, Wendy K Chung, Patricia A Ganz, Robert L Nussbaum, Journal of the National Cancer Institute
- A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer RiskPatricia A Ganz, Amanda E Toland, Susan M Domchek, Tanja Pejovic, Clinical Cancer Research
- Ethical Implications of Direct-to-Consumer Hereditary Cancer TestsSusan Domchek, MD, JAMA
Press Mentions
T-cell Response to mRNA Vaccine Improved with Cytokine AdjuvantJune 9th, 2025- Four Penn Cancer Researchers Inducted as Fellows of the AACR AcademyMarch 10th, 2025
- Clinical Trials Are Testing Ways to Prevent Breast CancerJanuary 15th, 2025
Grant Support
- University Of Pennsylvania Cancer Genetics NetworkNational Cancer Institute2002–2006
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
